2 are for Crohn's and 2 for UC each has a safety (long term extensions study). Yes the two main trials are listed as opening in October. Personally to me the most important thing is reading the trial design especially when the company hasn't disclosed it yet! I would say its worth a click and I have no compensation for the clicks :-)
News 
Market Data 
Discover 
